Learning Objectives:

  1. Review history of Ras oncogene and biology
  2. Discuss prior drug development strategies
  3. Present recent data on advances with a Ras G12C inhibitor
Session date: 
12/23/2019 - 12:00pm to 1:00pm CST
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael J. Breen, MD, PhD